IRC
CNMD icon

Investors Research Corp’s CONMED CNMD Stock Holding History

Investors Research Corp’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.6K Hold
415
– – ﹤0.01% 506
2026
Q1 		$14.7K Buy
415
+15
+4% +$610 ﹤0.01% 511
2025
Q4 		$16.2K Buy
+400
New +$17.4K ﹤0.01% 570

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Investors Research Corp's CNMD Position: Q2 2026 in Review

Investors Research Corp held its CONMED (CNMD) position steady in Q2 2026 at 415 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #506.

Investors Research Corp first reported a position in CNMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $16.2K in Q4 2025. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Investors Research Corp held 415 shares of CONMED worth $13.6K as of Q2 2026.
  • Investors Research Corp left its CONMED share count unchanged in Q2 2026.
  • CONMED made up ﹤0.01% of Investors Research Corp's portfolio in Q2 2026, its #506 holding.
  • Investors Research Corp first reported a position in CONMED in Q4 2025 and has held it in 3 quarters since.
  • Investors Research Corp's CONMED position peaked at $16.2K in Q4 2025.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Investors Research Corp's 13F filing for Q2 2026, filed 10 Jul 2026.